MAOA and breast neoplasm: Moreover, like the expression of BTIC markers such as aldehyde dehydrogenase [71] and CD44 [72], increased MAOA transcripts expression is associated with reduced relapse-free survival in high-grade breast tumors of the TNBC clinical subtype [57].